Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain:…
The constrained supply of Wegovy and the necessity of ongoing obesity management support are key considerations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
glucagon-like peptide-1 receptor
Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData
The National Institute for Health and Care Excellence (NICE) provided guidance in August 2023 explaining that where triple therapy…